Alessia Ruggieri

Title: Alessia Ruggieri: Innovator in Retroviral Research

Introduction

Alessia Ruggieri is a prominent inventor based in Mulhouse, France. She has made significant contributions to the field of retroviral research, particularly in the detection of human endogenous retroviruses. Her innovative work has led to the development of a patented method that enhances our understanding of retroviral proteins.

Latest Patents

Alessia Ruggieri holds a patent for a method for detecting the expression of an envelope protein of a human endogenous retrovirus. This method involves detecting the expression of a polypeptide in cells and identifying the interaction between a polypeptide and cells, either ex vivo or in vitro. The polypeptide is selected from a specific group, including a peptide comprising the cyt domain of the envelope protein of the human endogenous retrovirus, HERV-W. The detection is established by the fusogenic power of the polypeptide, demonstrated through syncytia formation. She has 1 patent to her name.

Career Highlights

Throughout her career, Alessia has worked with esteemed organizations such as the National Institute of Health and Medical Research and bioMérieux, Inc. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.

Collaborations

Alessia has collaborated with notable colleagues, including Francois Mallet and Francois-Loic Cosset. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Alessia Ruggieri is a trailblazer in the field of retroviral research, with her innovative methods paving the way for future discoveries. Her contributions are invaluable to the scientific community and continue to inspire further research in this critical area.